Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin
about
State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationNaturally occurring drug resistance associated variants to hepatitis C virus direct-acting antiviral agents in treatment-naive HCV genotype 1b-infected patients in China.The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease InhibitorsPrevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort.Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor TherapyInvestigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy.No correspondence between resistance mutations in the HCV-NS3 protease at baseline and early telaprevir-based triple therapy.Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients.
P2860
Q28079102-601A8A44-FA87-42E1-B2AC-2E464E4DD446Q33672648-C26A501E-D667-4C6F-9EB6-5CA1C2CEB94CQ36155389-B6888D45-3984-4332-9538-BF3BAEDAD4CBQ36506480-E5FCF811-AE26-4397-8CA7-0098295AAEF1Q36881967-14D71278-9B0E-4149-BA0A-DAD826206463Q36988456-43DA09EF-7FBF-4521-95CE-C3A4C61E0BF1Q40868771-5DFFD5BD-22E5-40EA-A643-C677DF67636FQ44104489-9E495360-C06A-439C-9E44-C6123EDBC9E1
P2860
Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical Implications of Detec ...... d With Peginterferon/Ribavirin
@ast
Clinical Implications of Detec ...... d With Peginterferon/Ribavirin
@en
Clinical Implications of Detec ...... d With Peginterferon/Ribavirin
@nl
type
label
Clinical Implications of Detec ...... d With Peginterferon/Ribavirin
@ast
Clinical Implications of Detec ...... d With Peginterferon/Ribavirin
@en
Clinical Implications of Detec ...... d With Peginterferon/Ribavirin
@nl
prefLabel
Clinical Implications of Detec ...... d With Peginterferon/Ribavirin
@ast
Clinical Implications of Detec ...... d With Peginterferon/Ribavirin
@en
Clinical Implications of Detec ...... d With Peginterferon/Ribavirin
@nl
P2093
P2860
P356
P1476
Clinical Implications of Detec ...... d With Peginterferon/Ribavirin
@en
P2093
Anita Y M Howe
Jianmin Long
John A Howe
Mark J DiNubile
Patricia McMonagle
Robert Chase
Seth Thompson
Stephanie Curry
Stuart Black
P2860
P304
P356
10.1093/OFID/OFU078
P577
2014-09-16T00:00:00Z